Skip to main content

Table 1 Characteristics of the sample by product type and WHO region, 2009 to 2018

From: Price, quality, and market dynamics of malaria rapid diagnostic tests: analysis of Global Fund 2009–2018 data

Characteristics of the sample by product type and WHO region (2009 to 2018)

 

Number of purchase orders (%)

Total RDT volume

(%)

Unique RDT product evaluations1,2 (%)

Unique manufacturers3

(%)

Total

925 (100%)

776,960,035 (100%)

39 (100%)

11 (100%)

Product type

P.f

403 (43.6%)

466,737,077 (60.1%)

19 (48.7%)

9 (81.8%)

P.f./Pan

372 (40.2%)

243,217,199 (31.3%)

10 (25.6%)

4 (36.4%)

P.f./P.v

147 (15.9%)

66,414,819 (8.5%)

9 (23.1%)

4 (36.4%)

Pan

3 (< 0.01%)

590,940 (< 0.01%)

1 (2.6%)

1 (9.1%)

WHO region4

AFRO

579 (62.6%)

695,556,122 (89.5%)

29 (74.6%)

7 (63.6%)

SEARO

115 (12.4%)

28,818,510 (3.7%)

18 (46.2%)

6 (54.5%)

EMRO

82 (08.9%)

29,664,394 (3.8%)

15 (38.5%)

3 (27.3%)

WPRO

75 (08.1%)

18,154,870 (2.3%)

9 (23.1%)

3 (27.3%)

AMRO

71 (07.7%)

4,411,119 (< 0.01%)

19 (48.7%)

8 (72.7%)

EURO

3 (< 0.01%)

355,020 (< 0.01%)

3 (7.7%)

1 (9.1%)

  1. 1 Certain RDTs were evaluated more than once by the WHO product testing programme and PDS scores were updated in the dataset after each round of testing
  2. 2 Unique RDT product evaluations by region do not total 100% because some RDTs were purchased in multiple regions
  3. 3 Unique manufacturers by product type and region do not total 100% because some manufacturers produce multiple product types and were purchased in multiple WHO regions
  4. 4 WHO regions are defined as the Regional Office for Africa (AFRO), the Americas (AMRO), Europe (EURO), the Eastern Mediterranean (EMRO), Southeast Asia (SEARO), and the Western Pacific (WPRO)